Almost a decade ago, the FDA approved daratumumab (Darzalex), a groundbreaking monoclonal antibody for multiple myeloma (MM). This marked a significant shift in the MM treatment landscape, ushering in an era of immunotherapies. Experts at the 2024 International Myeloma Society (IMS) Annual Meeting highlighted the evolution of these treatments, including bispecific and monoclonal antibodies, and […]
Tag Archives: progression-free survival
Pharmacy
Ribociclib Plus Endocrine Therapy Shows Consistent Benefit and Safety in Elderly Patients with Advanced Breast Cancer
The combination of ribociclib and endocrine therapy demonstrates consistent efficacy and a manageable safety profile across different age groups in patients with hormone receptor-positive (HR+), human epidermal growth factor receptor 2 (HER2)-negative advanced breast cancer. This conclusion stems from pooled analyses of the MONALEESA-2, -3, and -7 trials presented at the 2023 San Antonio Breast […]